MAKIMOTO A[Author] - Search Results

Year	Number of Results
1963	1
1994	3
1995	6
1997	1
1998	4
1999	3
2000	1
2001	4
2002	11
2003	10
2004	6
2005	4
2006	4
2007	6
2008	2
2009	2
2010	4
2011	2
2012	4
2013	3
2014	1
2017	2
2018	2
2019	2
2020	4
2021	4
2022	4
2023	6
2024	4

1

Editorial: Developmental therapeutics in pediatric neuro-oncology.

Makimoto A, Erdreich-Epstein A, Muragaki Y. Makimoto A, et al. Front Oncol. 2023 Jan 24;13:1134168. doi: 10.3389/fonc.2023.1134168. eCollection 2023. Front Oncol. 2023. PMID: 36761971 Free PMC article. No abstract available.

2

Optimizing Rhabdomyosarcoma Treatment in Adolescents and Young Adults.

Makimoto A. Makimoto A. Cancers (Basel). 2022 May 2;14(9):2270. doi: 10.3390/cancers14092270. Cancers (Basel). 2022. PMID: 35565399 Free PMC article. Review.

3

Tumor-Treating Fields Therapy for Pediatric Brain Tumors.

Makimoto A, Nishikawa R, Terashima K, Kurihara J, Fujisaki H, Ihara S, Morikawa Y, Yuza Y. Makimoto A, et al. Neurol Int. 2021 Apr 8;13(2):151-165. doi: 10.3390/neurolint13020015. Neurol Int. 2021. PMID: 33917660 Free PMC article. Review.

4

[Ewing sarcoma].

Hamanoue S, Makimoto A. Hamanoue S, et al. Among authors: makimoto a. Gan To Kagaku Ryoho. 2007 Feb;34(2):175-80. Gan To Kagaku Ryoho. 2007. PMID: 17301523 Japanese.

5

Cardiovascular toxicity of regorafenib for heavily-treated osteosarcoma.

Saito Y, Makimoto A, Miura M, Yuza Y. Saito Y, et al. Among authors: makimoto a. Pediatr Int. 2021 Jul;63(7):857-859. doi: 10.1111/ped.14503. Epub 2020 Dec 5. Pediatr Int. 2021. PMID: 33277804 No abstract available.

6

Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors.

Makimoto A, Fang J, Maeda H. Makimoto A, et al. Cancers (Basel). 2021 Jul 23;13(15):3698. doi: 10.3390/cancers13153698. Cancers (Basel). 2021. PMID: 34359599 Free PMC article. Review.

7

Autopsy-proven anaplastic large cell lymphoma mimicking TAFRO syndrome.

Akamine K, Hamada R, Makidono A, Okita K, Saito O, Makimoto A, Matsuoka K. Akamine K, et al. Among authors: makimoto a. Pediatr Int. 2023 Jan-Dec;65(1):e15561. doi: 10.1111/ped.15561. Pediatr Int. 2023. PMID: 37310132 No abstract available.

8

Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects.

Makimoto A, Fujisaki H, Matsumoto K, Takahashi Y, Cho Y, Morikawa Y, Yuza Y, Tajiri T, Iehara T. Makimoto A, et al. Cancers (Basel). 2024 Jan 26;16(3):544. doi: 10.3390/cancers16030544. Cancers (Basel). 2024. PMID: 38339295 Free PMC article. Review.

9

Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective.

Hayashi H, Makimoto A, Yuza Y. Hayashi H, et al. Among authors: makimoto a. Cancers (Basel). 2024 Feb 8;16(4):723. doi: 10.3390/cancers16040723. Cancers (Basel). 2024. PMID: 38398113 Free PMC article. Review.

10

Anaplastic lymphoma kinase status in rhabdomyosarcomas.

Yoshida A, Shibata T, Wakai S, Ushiku T, Tsuta K, Fukayama M, Makimoto A, Furuta K, Tsuda H. Yoshida A, et al. Among authors: makimoto a. Mod Pathol. 2013 Jun;26(6):772-81. doi: 10.1038/modpathol.2012.222. Epub 2013 Jan 11. Mod Pathol. 2013. PMID: 23307059 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year